Compounds > trovafloxacin
Page last updated: 2024-08-24

trovafloxacin and Abscess, Abdominal

trovafloxacin has been researched along with Abscess, Abdominal in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goldstein, EJ1
Brown, P; Chuah, SK; Esfandiari, A; Gollapudi, S; Hanna, N; Malilay, C; Polzer, RJ; Reddy, U; Thadepalli, F; Thadepalli, H1
Chuah, SK; Clark, R; Gollapudi, S; Hanna, N; Polzer, RJ; Reddy, U; Thadepalli, H1
Faro, S; Weigelt, JA1
Onderdonk, AB1
Alou, L; Anta, ML; Balcabao, IP; Del Potro, MG; Fuentes, F; Gomez-Lus, ML; Prieto, J1

Other Studies

6 other study(ies) available for trovafloxacin and Abscess, Abdominal

ArticleYear
Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2002, Sep-01, Volume: 35, Issue:Suppl 1

    Topics: Abdominal Abscess; Anti-Bacterial Agents; Aza Compounds; Bacteremia; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; beta-Lactams; Carbapenems; Clinical Trials as Topic; Ertapenem; Fluoroquinolones; Gemifloxacin; Humans; Indoles; Lactams; Moxifloxacin; Naphthyridines; Quinolines; Quinolones

2002
In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3

    Topics: Abdominal Abscess; Animals; Anti-Infective Agents; Bacteroides fragilis; Bacteroides Infections; Escherichia coli; Escherichia coli Infections; Fluoroquinolones; Male; Microbial Sensitivity Tests; Naphthyridines; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha

1997
Efficacy of trovafloxacin for treatment of experimental Bacteroides infection in young and senescent mice.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:9

    Topics: Abdominal Abscess; Aging; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides Infections; Clindamycin; Fluoroquinolones; Male; Mice; Naphthyridines; Tissue Distribution

1997
Antimicrobial therapy for surgical prophylaxis and for intra-abdominal and gynecologic infections.
    American journal of surgery, 1998, Volume: 176, Issue:6A Suppl

    Topics: Abdomen; Abdominal Abscess; Anti-Infective Agents; Antibiotic Prophylaxis; Female; Fluoroquinolones; Genital Diseases, Female; Humans; Naphthyridines; Surgical Wound Infection

1998
Pharmacodynamics and microbiology of trovafloxacin in animal models of surgical infection.
    American journal of surgery, 1998, Volume: 176, Issue:6A Suppl

    Topics: Abdominal Abscess; Animals; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria; Bacteroides fragilis; Biological Availability; Disease Models, Animal; Escherichia coli; Fluoroquinolones; Male; Mice; Naphthyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Surgical Wound Infection

1998
Efficacy of trovafloxacin in an in vitro pharmacodynamic simulation of an intraabdominal infection.
    International journal of antimicrobial agents, 1999, Volume: 12, Issue:2

    Topics: Abdominal Abscess; Anti-Infective Agents; Bacteroides fragilis; Enterococcus faecalis; Escherichia coli; Fluoroquinolones; Humans; Microbial Sensitivity Tests; Naphthyridines; Staphylococcus aureus; Time Factors

1999